Tom O'Brien


Prior to founding Eclipse in 1993, Tom held several leadership positions throughout his career in the medical device industry. Having mastered both disposable and capital equipment sales for companies like C.R. Bard, Tom’s track record of success quickly established Eclipse as the go-to company to launch new technology in the surgical laser industry.

Over time Tom transitioned Eclipse from a leader in the OR surgical laser market to a key player in the aesthetic laser industry. Starting in 2011 Eclipse began a new mission of increasing adoption of Platelet-rich Plasma on a national level.

His vision and leadership has helped Eclipse become one of the most successful medical device companies in its space. Tom’s new mission is to bring game-changing Eclipse technologies in Platelet-Rich Plasma, Microneedling and Shockwave Therapy to the entire globe.


Eclipse Aesthetics Wins Multiple Prestigious Aesthetic Everything® Diamond Crystal Awards

Industry leader garners top honors for aesthetics, skin-care and hair restoration devices
DALLAS, Sept. 25, 2017 /PRNewswire/ — Eclipse Aesthetics, LLC, a leader in aesthetics and medical supplies, is proud to announce the company has been recognized with three prestigious 2017 Aesthetic Everything® Diamond Crystal Awards including:
Top Aesthetics Companies Top Skin Care Devices Top Hair Restoration Devices

Industry award winners were selected by Aesthetic Everything® from over 10,000 votes cast on the aesthetic promoter’s website. The awards recognize companies and providers based on peer and customer nominations.

“Eclipse is truly honored to be the recipient of so many prominent awards,” said Tom O’Brien, CEO and Founder of Eclipse Aesthetics. “It is a privilege to be listed as a recipient along side some of the most prominent physicians, practices, companies and aesthetic leaders in our industry.” For 25 years, Eclipse has earned a reputation for providing superior solutions to the U.S. aesthetic and medical communities and has rapidly become a leader in the international aesthetic markets. Thousands of medical and skin-care professionals utilize Eclipse products in their practice in the United States and across the globe. The company has a portfolio of top-selling products including: Theradome®, laser helmet for hair regrowth; the award-winning Eclipse MicroPen® Elite*, micro-needling technology; dEp Patch™, micro-current mask and patches; and Crazy Cool® Hydro-Thermal Mask, among others. “Eclipse is excited about our latest product offering coming soon to the aesthetic marketplace,” Mr. O’Brien said. “The MicroPen® EVO** is the highly anticipated evolution of the Eclipse MicroPen® Elite. The all-new cordless dermal micro-needling device will retain all the features of its predecessor, but will also offer new capabilities never before available in a portable micro-needling pen.” With the simple change of a cartridge, users will have the option of selecting mechanical micro-needling, RF-based micro-needling or non-ablative bulk heating. Eclipse also provides medical supply and devices, such as Eclipse PRP™, platelet-rich plasma kits; and the all-new Eclipse eVIVE. “We look forward to bringing many new offerings to market,” Mr. O’Brien said. “We are confident these products will help advance practice offerings and patient results to the next level.” [link text=’Read More’ url=’https://www.prnewswire.com/news-releases/eclipse-aesthetics-wins-multiple-prestigious-aesthetic-everything-diamond-crystal-awards-300524115.html’]

For USA & Canada visitors: EclipseMedGlobal.com is an international website that has not been evaluated by the United States Food and Drug Administration. Statements and/or claims on this site are not intended to prevent, diagnose, treat or cure any ailments or diseases. Information and product/packaging on this site is for informational purposes only and is not intended as a substitution for advice from a physician or health-care professional. Information shown on this site may describe clearances in countries other than the USA and Canada, hence it may include indications and information that are outside the scope of FDA-cleared labeling.

Do you understand and want to proceed?

Yes, please proceed


Visit the Eclipse USA Site